• Silvia Takanohashi Kobayashi, Alessandro Gonçalves Campolina, DizMaria Del Pilar EstevezMDPE0000-0003-3176-9747MD, PhD. Attending Physician, Centro de Investigação Translacional em Oncologia, Instituto do Câncer do Estado de São Paulo (ICESP), Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, BR, and SoárezPatrícia Coelho dePC0000-0001-8383-0728MPH, PhD. Associate Professor, Department of Preventive Medicine, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, BR..
• MD, MSc. Ophthalmologist, Centro de Investigação Translacional em Oncologia, Instituto do Câncer do Estado de São Paulo (ICESP), Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, BR.
• Sao Paulo Med J. 2019 Sep 1; 137 (5): 438445438-445.

BackgroundManagement of rectal cancer has become more complex with multimodality therapy (neoadjuvant chemoradiotherapy and surgery) and this has led to the need to organize multidisciplinary teams. The aim of this study was to report on the planning, implementation and evaluation of an integrated care pathway for neoadjuvant treatment of middle and lower rectal cancer.Design And SettingThis was a cross-sectional post-implementation study that was carried out at a public university cancer center.MethodsThe Framework for Program Evaluation in Public Health of the Centers for Disease Control and Prevention (CDC) was used to identify resources and activities; link results from activities and outcomes with expected goals; and originate indicators and outcome measurements.ResultsThe logic model identified four activities: stakeholders' engagement, clinical pathway development, information technology improvements and training programs; and three categories of outcomes: access to care, effectiveness and organizational outcomes. The measurements involved 218 patients, among whom 66.3% had their first consultation within 15 days after admission; 75.2% underwent surgery < 14 weeks after the end of neoadjuvant treatment and 72.7% completed the treatment in < 189 days. There was 100% adherence to the protocol for the regimen of 5-fluorouracil and leucovorin.ConclusionsThe logic model was useful for evaluating the implementation of the integrated care pathways and for identifying measurements to be made in future outcome studies.

21 keywords...

hide…